The Aspire deal does help us move forward with the capital requirements to move to Nasdaq. Once the data comes out we will uplist to Nasdaq to become a 10 buck stock. The future big pharma deal will be the impetus for meeting the requirements for the new exchange.

The nice thing about the future PRs is that daytraders can't predict the importance of each one so they will screw themselves out of massive returns by nickle and diming trades.

Great day!